Clinical Pharmacology
Kura Oncology
Amitava is currently Senior Director of Clinical Pharmacology at Kura Oncology, where he supports global drug development programs. He has 16 years of experience in the pharmaceutical industry supporting various therapeutic areas and has previously worked at Merck Novartis and J&J. Amitava has a PhD in Pharmaceutical Sciences from University of Maryland, Baltimore. Amitava’s main research interests include clinical pharmacology, modeling & simulation, pharmacokinetics, and biopharmaceutics. He has interacted with several regulatory agencies like FDA, EMA and PMDA on these topics, as part of project support as well as in workshops and consortia. Amitava has published more than 50 research and review articles, and has 30 podium presentations in national & international conferences, on these topics. Amitava has won several awards including the Novartis VIVA Leading Science award in 2019 for his modeling efforts, an award that celebrates exceptional contribution by scientists across the company’s R&D organization worldwide. Amitava actively volunteers in several consortia and scientific organizations such as IQ, IMI, AAPS and ASCPT. Amitava teaches a course on Clinical Pharmacology at University of Maryland and Jefferson University.
Disclosure information not submitted.
Tuesday, October 18, 2022
3:00 PM – 4:00 PM ET